A Double blind (3rd party open), parallel group, placebo controlled single dose and multiple escalating oral dose study to investigate the safety, toleration and pharmacokinetics of UK-427,857 in healthy male subjects
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/PR00009148/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
Vivli是一家独立的非营利组织,开发了面向国际科研共同体全环节的全球数据共享与分析平台。该组织的使命是通过构建并推行可持续的全球数据共享体系,促进、协调并助力临床研究数据的科学共享与复用。Vivli平台包含独立数据存储库、深度搜索引擎以及基于云架构的安全分析平台。
提供机构:
Vivli
创建时间:
2023-08-15



